Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0E9HQ
|
||||
| Former ID |
DCL000618
|
||||
| Drug Name |
R7334
|
||||
| Synonyms |
R 7334; 2-Nitro-6,7,8,9-tetrahydronaphtho(1,2-b)furan; 2-nitro-6,7,8,9-tetrahydrobenzo[g][1]benzofuran; 6,7,8,9-Tetrahydro-2-nitronaphtho(1,2-b)furan
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Macular degeneration [ICD9: 362.5; ICD10:H35.3] | Phase 1 | [522356] | ||
| Company |
Roche
|
||||
| Formula |
C12H11NO3
|
||||
| Canonical SMILES |
C1CCC2=C(C1)C=CC3=C2OC(=C3)[N+](=O)[O-]
|
||||
| InChI |
1S/C12H11NO3/c14-13(15)11-7-9-6-5-8-3-1-2-4-10(8)12(9)16-11/h5-7H,1-4H2
|
||||
| InChIKey |
DZLOYALXDCQGTA-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Placenta growth factor | Target Info | [551607] | ||
| NetPath Pathway | TSH Signaling Pathway | ||||
| Pathway Interaction Database | VEGFR1 specific signals | ||||
| WikiPathways | Focal Adhesion | ||||
| Signaling by VEGF | |||||
| References | |||||